Hatch-waxman Amendments; Method of Use Patents; Prescription Drug Use Code; Prescription Drugs; Patent Infringement; Act of Infringement; Intellectual Property Law; Generic Manufacturer; Generic Drugs; Patent Infringement Counterclaim; Food and Drug Administration (f.d.a.); Patents
Federal Or State Consumer Protection: Typically Under the Truth in Lending, Food, Drug and Cosmetic, and Consumer Protection Credit Acts; Economic Activity
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S, 566 U.S. 399 (2012). https://www.govinfo.gov/app/details/USREPORTS-566/USREPORTS-566-399.
APA
Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S, 566 U.S. 399 (2012). https://www.govinfo.gov/app/details/USREPORTS-566/USREPORTS-566-399.
MLA
United States, Supreme Court. Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S. United States Reports, vol. 566, 17 April 2012, p. 399. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/USREPORTS-566/USREPORTS-566-399.
Bluebook
Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S, 566 U.S. 399 (2012).
